Joint Effect of Genotypic and Phenotypic Features of Reproductive Factors on Endometrial Cancer Risk

Sci Rep. 2015 Oct 26:5:15582. doi: 10.1038/srep15582.

Abstract

Prolonged estrogen exposure is believed to be the major cause of endometrial cancer. As possible markers of estrogen exposure, various menstrual and reproductive features, e.g., ages at menarche and menopause, are found to be associated with endometrial cancer risk. In order to assess their combined effects on endometrial cancer, we created the total number of menstrual cycles (TNMC) that a woman experienced during her life or up to the time of study and two genetic risk scores, GRS1 for age at menarche and GRS2 for age at menopause. Comparing 482 endometrial cancer patients with 571 population controls, we found TNMC was associated with endometrial cancer risk and that the association remained statistically significant after adjustment for obesity and other potential confounders. Risk increased by about 2.5% for every additional 10 menstrual-cycles. The study also showed that high GRS1 was associated with increased risk. This relationship, however, was attenuated after adjustment for obesity. Our study further indicated women with high TNMC and GRS1 had twice the risk of endometrial cancer compared to those low in both indices. Our results provided additional support to the involvement of estrogen exposure in endometrial cancer risk with regard to genetic background and lifestyle features.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adolescent
  • Aged
  • Child
  • Endometrial Neoplasms / epidemiology
  • Endometrial Neoplasms / genetics*
  • Estrogens
  • Female
  • Genetic Predisposition to Disease*
  • Genotype
  • Humans
  • Menstrual Cycle*
  • Middle Aged
  • Phenotype
  • Polymorphism, Single Nucleotide
  • Risk Factors

Substances

  • Estrogens